花柏格米亚的第二次生命:使用废物微封装作为生物活性化合物的宝贵来源,对一种新配方的生物可用性分析
Maria Serra1, Roberta Macrì2, Sonia Bonacci3
1Pharmacology Laboratory, Institute of Research for Food Safety and Health IRC-FSH, Department of Health Sciences, University Magna Graecia of Catanzaro, Catanzaro, 88100, Italy.
Pharmacological reports : PR
|July 24, 2025
概括
一种新的封装技术在体内显著提高了Bergamot聚醇分数 (BPF) 代谢物的生物可用性和稳定性. 与标准或微缩版本相比,这种配方可以改善有益化合物的长期递送.
科学领域:
- 药理学 药理学是指药理学的学科.
- 营养保健品 营养保健品
- 代谢学 代谢学 代谢学
背景情况:
- 多提供健康益处,但其生物可用性较差.
- 活体中代谢物可能对多的生物活性负责.
- 改变肠道微生物群会影响多器官功能,这表明代谢产物的作用.
研究的目的:
- 为了表征一种新的果多分离 (BPF) 配方.
- 为了提高代谢物的生物可用性和长期稳定性.
- 在BPF配方中使用可持续的生产方法.
主要方法:
- 雄性Sprague-Dawley大鼠被口服标准BPF,微缩BPF (BPFmicro) 或封装BPF (BPFencap).
- 采集血液样本并使用超高性能液态染色学-并联质谱法 (UHPLC-MS/MS) 分析初级和二级代谢物.
主要成果:
- 与BPF和BPF微小组相比,BPFencap组的纳林金及其代谢物度显著更高.
- 曲线下面面积 (AUC) 分析显示,BPFencap组中的代谢物水平明显升高,BPF微组中的水平相对于BPF相对降低.
结论:
- 微化 (BPFmicro) 暂时增加了生物可用性,但缺乏长期稳定性.
- 新的封装BPF (BPFencap) 配方显著改善了随着时间的推移,代谢物的生物可用性和稳定性.
关键词:
贝加莫特的多分离物.生物可用性 生物可用性类植物的白色纤维.封装封装是一种封装.绿色化学是一种绿色化学.炎症 炎症是一种炎症.微化的微化.营养保健品 营养保健品氧化应激是一种氧化应激.聚醇是一种多醇.更多相关视频
07:42Author Spotlight: Development and Characterization of Eco-Friendly Lignin-Based Microparticles for Enhanced Delivery of Bioflavonoids
Published on: March 1, 2024
864
13:16A Whole Cell Bioreporter Approach to Assess Transport and Bioavailability of Organic Contaminants in Water Unsaturated Systems
Published on: December 24, 2014
10.5K
相关概念视频
01:23Factors Influencing Bioavailability: First-Pass Elimination
7.0K
When a drug is taken orally, it undergoes a journey starting from the gastrointestinal (GI) tract, passing through the portal vein, reaching the liver, and finally entering the systemic circulation. This process involves the absorption of the drug across the GI tract. The liver is the primary site for metabolizing the drug, with some metabolism also occurring in the gut wall. This journey significantly reduces the quantity of the drug that reaches the systemic circulation, a phenomenon known as...
7.0K
01:13Bioavailability: Overview
3.1K
Bioavailability refers to the proportion of an unaltered drug that, after administration, enters the systemic circulation and can be distributed to the desired action site. Factors such as gastrointestinal (GI) absorption and liver biotransformation influence the bioavailability of a drug when it is administered orally. When a drug is administered intravenously, it enters the systemic circulation directly; by definition, its bioavailability is assumed to be 100%. The bioavailability of an...
3.1K